Are hematopoietic colony-stimulating factors useful in association with chemotherapy in the treatment of HIV-related non-Hodgkin's lymphomas?

被引：0
|
作者：
Errante, D [1 ]
Vaccher, E [1 ]
Tirelli, U [1 ]
机构：
[1] CTR RIFERIMENTO ONCOL,DIV MED ONCOL & AIDS,I-33081 AVIANO,ITALY
来源：
ANNALS OF ONCOLOGY | 1996年 / 7卷 / 03期
关键词：
colony stimulating factors; HIV; non-Hodgkin's lymphoma; treatment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：233 / 237
页数：5
相关论文
共 50 条
  • [41] Inclusion of Rituximab in Treatment Protocols for Non-Hodgkin's Lymphomas and Risk for Progressive Multifocal Leukoencephalopathy
    Tuccori, Marco
    Focosi, Daniele
    Blandizzi, Corrado
    Pelosini, Matteo
    Montagnani, Sabrina
    Maggi, Fabrizio
    Pistello, Mauro
    Antonioli, Luca
    Fornai, Matteo
    Pepe, Pasquale
    Rossi, Giuseppe
    Petrini, Mario
    ONCOLOGIST, 2010, 15 (11) : 1214 - 1219
  • [42] How the discovery of rituximab impacted the treatment of B-cell non-Hodgkin's lymphomas
    Mohammed, Raihan
    Milne, Artemis
    Kayani, Kayani
    Ojha, Utkarsh
    JOURNAL OF BLOOD MEDICINE, 2019, 10 : 71 - 84
  • [43] Long term follow-up of CEOP in the treatment of HIV related non-Hodgkin's lymphoma (NHL)
    Davis, AJ
    Goldstein, D
    Milliken, S
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1998, 28 (01): : 28 - 32
  • [44] Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma
    Scadden, DT
    Schenkein, DP
    Bernstein, Z
    Luskey, B
    Doweiko, J
    Tulpule, A
    Levine, AM
    CANCER, 1998, 83 (12) : 2580 - 2587
  • [45] Successful treatment of aggressive HIV-associated non-Hodgkin's lymphoma with combination chemotherapy, biotherapy with Rituximab and HAART: Presentation of a therapeutic option
    Klepfish, A
    Schattner, A
    Shvidel, L
    Shtalrid, M
    Haran, M
    Bentwich, Z
    Berrebi, A
    LEUKEMIA & LYMPHOMA, 2003, 44 (02) : 349 - 351
  • [46] Expression of tenascin is related to histologic malignancy and angiogenesis in B-Cell non-Hodgkin's lymphomas
    Vacca, A
    Ribatti, D
    Fanelli, M
    Costantino, F
    Nico, B
    DiStefano, R
    Serio, G
    Dammacco, F
    LEUKEMIA & LYMPHOMA, 1996, 22 (5-6) : 473 - 481
  • [47] Radiotherapy alone or combined radio-/chemotherapy for primary non-Hodgkin's lymphomas of the central nervous system
    Kortmann, RD
    Bamberg, M
    Budach, W
    Hoffmann, W
    Herrlinger, U
    Clemens, MR
    TUMORDIAGNOSTIK & THERAPIE, 1996, 17 (04) : 106 - 115
  • [48] Long-term results of total abdominopelvic irradiation in non-Hodgkin's lymphomas after failure of chemotherapy
    Mahé, MA
    Bourdin, S
    Le Mevel, A
    Moreau, P
    Moreau, A
    Hamidou, M
    Gaillard, F
    Rapp, MJ
    Milpied, N
    Harousseau, JL
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (01): : 117 - 121
  • [49] Prolonged survival with HIV-1 related nasal non-Hodgkin's lymphoma
    DilkeWing, GM
    Monteiro, EF
    INTERNATIONAL JOURNAL OF STD & AIDS, 1997, 8 (11) : 704 - 706
  • [50] A humanized HLA-DR antibody (hu1D10, apolizumab) in combination with granulocyte colony-stimulating factor (filgrastim) for the treatment of non-Hodgkin's lymphoma: A pilot study
    Rech, Juergen
    Repp, Roland
    Rech, Dorit
    Stockmeyer, Bernhard
    Dechant, Michael
    Niedobitek, Gerald
    Gramatzki, Martin
    Valerius, Thomas
    LEUKEMIA & LYMPHOMA, 2006, 47 (10) : 2147 - 2154
12345